Value of the CHA₂ DS₂ -VASc score for predicting outcome in patients with heart failure.

ABSTRACT:

Aims

Comorbidities are highly prevalent in patients with heart failure (HF) and affect clinical outcome. The CHA₂ DS₂ -VASc score is a validated score to estimate assessment of thromboembolic risk in patients with atrial fibrillation.

Methods and results

We evaluated the predictive value of this score on clinical outcome in patients with HF. All patients with a diagnosis of chronic HF at a health maintenance organization were evaluated for the CHA₂ DS₂ -VASc score. Patients were followed for cardiac related hospitalizations and death. The cohort included 7106 HF patients. Mean follow-up was 744 days; the median CHA₂ DS₂ -VASc score was 5.0 (range 4.0-6.0). The CHA₂ DS₂ -VASc score was a s

SUBMITTER: Shuvy M 

PROVIDER: S-EPMC7524134 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature